These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 17108013

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.
    Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
    Gibran SK, Khan K, Jungkim S, Cleary PE.
    Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S, Rush R, Natarajan S, Gillies M.
    Clin Exp Ophthalmol; 2011 May; 39(7):673-81. PubMed ID: 22452685
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
    Negi AK, Vernon SA, Lim CS, Owen-Armstrong K.
    Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S.
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA, Melo LA, Costa RA, Skaf M, Belfort R, Souza-Filho AA, Farah ME, Kuppermann BD.
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema.
    Karacorlu M, Ozdemir H, Senturk F, Karacorlu SA, Uysal O.
    Acta Ophthalmol; 2010 Aug; 88(5):558-63. PubMed ID: 19432873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.